Lilly pitches plan to overcome key patent losses

INDIANAPOLIS—Eli Lilly and Co., only months away from losing patent protection for its top-selling drug, told investors Thursday the keys to overcoming this and other patent losses lie in its labs and emerging markets like China. The company has 33 potential drugs in mid- or late-stage testing in its development pipeline. Company leaders said during a webcast of a meeting with the...